Interaction studies of withania somnifera’s key metabolite withaferin a with different receptors associated with cardiovascular disease

Current Computer-Aided Drug Design

Volumn 11, Issue 3, 2015, Pages 212-221

  Ravindran, Rekha ^a   Sharma, Nitika ^a   Roy, Sujata ^a   Thakur, Ashoke R ^b   Ganesh, Subhadra ^a   Kumar, Sriram ^a   Devi, Jamuna ^a   Rajkumar, Johanna ^a  

^a RAJALAKSHMI ENGINEERING COLLEGE   (India)

^b TECHNO INDIA UNIVERSITY   (India)

Author keywords

Ashwagandha; Beta receptor; Docking; Herbal

Indexed keywords

CARDIOLOGY; DISEASES; HYDROGEN BONDS; LEAD COMPOUNDS; MOLECULES;

ASHWAGANDHA; BETA RECEPTOR; CARDIOVASCULAR DISEASE; DOCKING; DOCKING STUDIES; HERBAL; INTERACTION STUDIES; MOLECULAR MECHANISM; RECEPTORS PROTEINS; WITHANIA SOMNIFERA;

METABOLITES;

BETA 1 ADRENERGIC RECEPTOR; CARAZOLOL; DIPEPTIDYL CARBOXYPEPTIDASE; ESTROGEN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; LISINOPRIL; SIMVASTATIN; WITHAFERIN A; XANTHINE DEHYDROGENASE; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A; ACYL COENZYME A; C REACTIVE PROTEIN; LIGAND; WITHANOLIDE;

ARTICLE; CARDIOVASCULAR DISEASE; CHEMICAL STRUCTURE; CLUSTER ANALYSIS; COMPUTER MODEL; COMPUTER SIMULATION; DRUG INTERACTION; DRUG MECHANISM; ENZYME ACTIVITY; HYDROGEN BOND; LIGAND BINDING; MOLECULAR DOCKING; PHARMACOPHORE; PHYSICAL CHEMISTRY; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; WITHANIA SOMNIFERA; METABOLISM; WITHANIA;

ACYL COENZYME A; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; LIGANDS; MOLECULAR DOCKING SIMULATION; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ESTROGEN; WITHANIA; WITHANOLIDES; XANTHINE DEHYDROGENASE;

EID: 84959548594     PISSN: 15734099     EISSN: 18756697     Source Type: Journal    
DOI: 10.2174/1573409912666151106115848     Document Type: Article

References (32)

1. Aje, T.O.; Miller, M. Cardiovascular disease: A global problem extending into the developing world. World J. Cardiol., 2009, 1, 3-10.
2. Zheng, C.J.; Han, L.Y.; Yap, C.W.; Ji, Z.L.; Cao, Z.W.; Chen, Y.Z. Therapeutic targets: progress of their exploration and investigation of their characteristics. Pharmacol. Rev., 2006, 58(2), 259-279.
3. Flordellis, C.; Papathanasopoulos, P.; Lymperopoulos, A.; Matsoukas, J.; Paris, H. Emerging therapeutic approaches multitargeting receptor tyrosine kinases and g protein-coupled receptors in cardiovascular disease. Cardiovasc. Hematol. Agents Med. Chem., 2007, 5(2), 133-145.
4. Sanjoy, K.P.; Yogeshwer, S. Herbal medicine: current status and the future. Asian Pac. J. Cancer Prev., 2003, 4, 281-288.
5. Mashour, N.H.; Lin, G.I.; Frishman, W.H. Herbal medicine for the treatment of cardiovascular disease clinical considerations. Arch. Intern. Med., 1998, 158(20) 2225-2234.
6. Dhuley, J.N. Adaptogenic and cardioprotective action of ashwagandha in rats and frogs. J. Ethnopharmacol., 2000, 70(1), 57-63.
7. Mallika, J.; Shyamala Devi, C.S. Effect of ambrex (an amber based formulation) on gastric mucosal damage: role of antioxidant enzymes and lipid profile. Indian J. Physiol. Pharmacol., 2004, 48(3) 343-347.
8. Siddiqui, Nasir Ali.; Singh, S.; Mairaj, M. S., Tajdar, H.K. Immunomodulatory effect of Withania somnifera, Asparagus racemosus and Picrorhiza kurroa roots. Int. J. Pharmacol., 2012, 8, 108-114.
9. Sitansu, K.V.; Ajay, K. Therapeutic uses of Withania somnifera (Ashwagandha) with a note on withanolides and its pharmacological actions. Asian J. Pharm. Clin. Res., 2011, 4(1), 1-4.
10. Murakami, H.T.; Kishi, A.; Yoshikawa, M. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera Dunal. And inhibitory activity for tachyphylaxis to clonidine in isolated guineapig ileum. Bioorg. Med. Chem., 2001, 9(6), 1499-1507.
11. Grover, A.; Shandilya, A.; Punetha, A.; Bisaria, V.S.; Sundar, D. Inhibition of the MO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A. BMC Genomics, 2010, 11(S4), 25.
12. Trott, O.; Olson, A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J. Comput. Chem. 2010, 31(2), 455-461.
13. Sayle, R.A.; Milner-White, E.J. RASMOL: biomolecular graphics for all. Trends Biochem. Sci., 1995, 20(9), 374.
14. DeLano, W.L. The PyMOL Molecular Graphics System. San Carlos, CA. DeLano Scientific, 2002.
15. Sadowski, J.; Gasteiger, J.; Klebe, G. Comparison of automatic three-dimensional model builders using 639 X-ray structures. J. Chem. Inf. Model., 1994, 34, 1000-1008.
16. Sadowski, J.; Schwab, C.; Gasteiger, J. CORINA, 3D Structure Generator: version 3.1, Molecular Networks GmbH, Erlangen, Germany, 2003.
17. Thompson, M. ArgusLab 4.0.1., Planaria software LLC, Seattle, Wash, USA, 2004.
18. Tiwari, A.; Panigrahi, S.K. HBAT: a complete package for analysing strong and weak hydrogen bonds in macromolecular crystal structures. In Silico Biol., 2007, 7(6), 651-661.
19. Rajan, S.; Baek, K.; Yoon, H.S. C-H…O hydrogen bonds in FK506-binding protein-ligand interactions. J. Mol. Recognit., 2013, 26(11), 550-555.
20. Sarkhel, S.; Desiraju, G.R. N-H…O, O-H…O, and C-H…O hydrogen bonds in protein-ligand complexes: strong and weak interactions in molecular recognition. Proteins, 2004, 54(2), 247-259.
21. Horowitz, S.; Raymond C.T. Carbon-oxygen hydrogen bonding in biological structure and function. J. Biol. Chem. 2012, 287(50), 41576-41582.
22. Horowitz, S.; Lynnette Dirk, M.A.; Yesselman, J.D.; Nimtz, J.S.; Adhikari, U.; Mehl, R.A.; Scheiner, S.; Houtz, R.L.; Al-Hashimi, H.M.; Trievel, R.C. Conservation and functional importance of carbon−oxygen. hydrogen bonding in AdoMet-dependent methyltransferases. J. Am. Chem. Soc., 2013, 135, 15536-15548.
23. Backman, T.W.; Cao, Y.; Girke, T. ChemMine tools: an online service for analyzing and clustering small molecules. Nucleic Acids Res., 2011, 39(Web Server issue), W486-W91.
24. Schneidman-Duhovny, D.; Dror, O.; Inbar, Y.; Nussinov, R.; Wolfson, H.J. Deterministic pharmacophore detection via multiple flexible alignment of drug-like molecules. J. Comput. Biol., 2008, 15(7): 737-754.
25. Schneidman-Duhovny, D.; Dror, O.; Inbar, Y.; Nussinov, R.; Wolfson, H.J. PharmaGist: a webserver for ligand-based pharmacophore detection. Nucleic Acids Res., 2008, 36(Web Server issue), W223-W228.
26. Jin, Y.; Junhong, W.; Shushu, Z.; Xiangjian, C.; Hengfang, W.; Jinan, Z. C-reactive protein augments hypoxia-induced apoptosis through mitochondrion-dependent pathway in cardiac myocytes. Mol. Cell. Biochem., 2008, 310, 215-226.
27. Suresh, P.; Palanisamy, P.; Farook, J.; Athimoolam, A.; Babu, S.P.; Sathiyamoorthy, S.; Rajaram, V. The role of statin drugs in combating cardiovascular diseases. Int. J. Curr. Res., 2011, 1(2) 47-56.
28. Nishant, P.; Visavadiya, A.V.; Narasimhacharya, R.N. Hypocholesteremic and antioxidant effects of Withania somnifera(Dunal) in hypercholesteremic rats. Phytomedicine, 2007, 14, 136-142.
29. Biswajit, A.; Jayaram, H.; Achintya, M.; Bruce, A.; Shibnath, G. A standardized Withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: a doubleblind, randomized, Placebo-controlled study. JANA, 2008, 11(1).
30. Nileeka Balasuriya, B.W.; Vasantha Rupasinghe, H.P. Plant flavonoids as angiotensin converting enzyme inhibitors in regulation of hypertension. Funct. Food Health Dis., 2011, 5, 172-188.
31. Wallukat, G. The beta-adrenergic receptors. Herz, 2002, 27(7), 683-90.
32. Barkhem, T.; Nilsson, S.; Gustafsson, J.A. Molecular mechanisms, physiological consequences and pharmacological implications of estrogen receptor action. Am. J. Pharmacogenomics., 2004, 4(1), 19-28.